Alcon AG (ALC)vsBionano Genomics Inc (BNGO)
ALC
Alcon AG
$75.26
+1.37%
HEALTHCARE · Cap: $37.11B
BNGO
Bionano Genomics Inc
$1.20
+1.69%
HEALTHCARE · Cap: $11.13M
Smart Verdict
WallStSmart Research — data-driven comparison
Alcon AG generates 36115% more annual revenue ($10.40B vs $28.72M). ALC leads profitability with a 9.4% profit margin vs -134.4%. ALC earns a higher WallStSmart Score of 49/100 (D+).
ALC
Hold49
out of 100
Grade: D+
BNGO
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-489.8%
Fair Value
$13.46
Current Price
$75.26
$61.80 premium
Intrinsic value data unavailable for BNGO.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Reasonable price relative to book value
Conservative balance sheet, low leverage
Revenue surging 21.3% year-over-year
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
ROE of 4.5% — below average capital efficiency
Earnings declined 22.2%
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -78.2% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ALC
The strongest argument for ALC centers on Debt/Equity, Price/Book.
Bull Case : BNGO
The strongest argument for BNGO centers on Price/Book, Debt/Equity, Revenue Growth. Revenue growth of 21.3% demonstrates continued momentum.
Bear Case : ALC
The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.
Bear Case : BNGO
The primary concerns for BNGO are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
ALC profiles as a value stock while BNGO is a growth play — different risk/reward profiles.
BNGO carries more volatility with a beta of 1.72 — expect wider price swings.
BNGO is growing revenue faster at 21.3% — sustainability is the question.
ALC generates stronger free cash flow (489M), providing more financial flexibility.
Bottom Line
ALC scores higher overall (49/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alcon AG
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Visit Website →Bionano Genomics Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?